Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance밤라니비맙/에테세비맙 치료 중 SARS-CoV-2 스파이크 단백질의 Q493R 돌연변이 출현 및 바이러스 제거 저항성 Published on 2022-02-012022-09-11 Journal: The Journal of Infection [키워드] emergence Mutation SARS-CoV-2 spike protein Treatment viral clearance [저자] Aurélie Guigon, Emmanuel Faure, Chloé Lemaire, Marie-Charlotte Chopin, Claire Tinez, Ady Assaf, Mouna Lazrek, Didier Hober, Laurence Bocket, Ilka Engelmann, Enagnon Kazali Alidjinou [Category] COVID19(2023년), SARS, 변종, 진단, PMC URL [DOI] 10.1016/j.jinf.2021.08.033 [Article Type] Article [Source] PMC All Keywords 【제목키워드】 Treatment, Mutation, viral clearance, emergence, SARS-CoV-2 spike protein,